Systemic and cardiac susceptibility of immune compromised mice to doxorubicin

Abstract Background Anthracycline chemotherapy is an effective and widely used treatment for solid tumors and hematological malignancies regardless of its known cardiotoxicity. The mechanisms of the cardiotoxicity are not fully understood and methods to protect the heart during or following anthracy...

Full description

Bibliographic Details
Published in:Cardio-Oncology
Main Authors: Amanda J. Favreau-Lessard, Hagen Blaszyk, Michael A. Jones, Douglas B. Sawyer, Ilka M. Pinz
Format: Article
Language:English
Published: BMC 2019-04-01
Subjects:
Anthracycline cardiotoxicity
Doxorubicin
Immune compromised mice
Online Access:http://link.springer.com/article/10.1186/s40959-019-0037-6

Internet

http://link.springer.com/article/10.1186/s40959-019-0037-6

Similar Items